NCT07310784 2026-03-03A Phase II Trial of LM103 in Advanced MelanomaSuzhou BlueHorse Therapeutics Co., Ltd.Phase 2 Recruiting92 enrolled
NCT06346067 2026-02-27A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)Erasca, Inc.Phase 3 Active not recruiting78 enrolled